Gastroenterology in the 21st Century: Optimizing Patient Outcomes
7 courses 1 CME each
Approach to the Patient with Abnormal Liver Function Studies
A New Era in the Management of Chronic Hepatitis C
Recent Advances in GI Endoscopy: What the Primary Care Physician Needs to Know
Inflammatory Bowel Disease: What Every Clinician Needs to Know
Screening for Colorectal Cancer: Occult Blood Testing, Flexible Sigmoidoscopy, Colonoscopy or CT Colography
Rethinking Clostridium Difficile: Old Bug, New Challenges
Nonalcoholoic Steatohepatitis (NASH): An Emerging Epidemic
Optimally select patients in each therapeutic area who will most benefit from novel treatment options
• Describe the application of biomarkers to prediction of treatment response in GI diseases covered in the conference
• Revise office-based management of chronic GI diseases, such as HCV, HBV, NASH, celiac disease, GERD and BE by applying timely interventions and increasing therapy adherence
• Recognize risk factors for disease progression among those infected with HCV or HBC or suffering from celiac disease, NASH, IBD, GERD, or BE and successfully manage these challenging cases
• Manage side effects associated with combination therapies used to treat complex GI illnesses
7 courses 1 CME each
Approach to the Patient with Abnormal Liver Function Studies
A New Era in the Management of Chronic Hepatitis C
Recent Advances in GI Endoscopy: What the Primary Care Physician Needs to Know
Inflammatory Bowel Disease: What Every Clinician Needs to Know
Screening for Colorectal Cancer: Occult Blood Testing, Flexible Sigmoidoscopy, Colonoscopy or CT Colography
Rethinking Clostridium Difficile: Old Bug, New Challenges
Nonalcoholoic Steatohepatitis (NASH): An Emerging Epidemic
Optimally select patients in each therapeutic area who will most benefit from novel treatment options
• Describe the application of biomarkers to prediction of treatment response in GI diseases covered in the conference
• Revise office-based management of chronic GI diseases, such as HCV, HBV, NASH, celiac disease, GERD and BE by applying timely interventions and increasing therapy adherence
• Recognize risk factors for disease progression among those infected with HCV or HBC or suffering from celiac disease, NASH, IBD, GERD, or BE and successfully manage these challenging cases
• Manage side effects associated with combination therapies used to treat complex GI illnesses
1-7 Free AMA CEUs for Physicians (Take one or all seven)
Expires 5/7/14
This educational activity is supported by independent medical educational grants from Shire, ViroPharma Incorporated, UCB, Inc., and Ferring Pharmaceuticals, Inc.
Sponsored by
Sponsored by